Emily Kaiser

Articles

European Commission approves faricimab for treatment of wet AMD, DME

September 19, 2022

Roche’s treatment of faricimab is the first and only FDA-approved medicine targeting two distinct pathways, angiopoietin (Ang)-2 and vascular endothelial growth factor (VEGF)-A, that often cause retinal diseases that may cause visual loss.